Learn more about Biophysical characterization with the Creoptix WAVEsystemEvent date: 07.09.2022
Time: 13:45 – 16:45 CET
Location: DiNAQOR AG, Wagistrasse 25, 8952 Schlieren
Pushing the Boundaries in Biomolecular Interaction Analysis with the Creoptix WAVEsystem and waveRAPID – From Biologics to Fragment-Based Drug Discovery.
We’re visiting six locations across the EU and the US to deliver the latest insights into binding kinetics and affinity – from fragment-based to biologics drug discovery.
- Edward A. FitzGerald – Application Scientist
- Michael Hennig – CEO of leadXpro